CIK 0001853816
- Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | WIERENGA WENDELL Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2025-01-13 | WIERENGA WENDELL Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-01-04 | WIERENGA WENDELL Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-10-06 | WIERENGA WENDELL Director | Grant or award | +20,654 | 62,398 | ||
| 2022-07-07 | WIERENGA WENDELL Director | Grant or award | +18,110 | 41,744 | ||
| 2022-04-07 | WIERENGA WENDELL Director | Grant or award | +10,593 | 15,471 | ||
| 2022-01-03 | WIERENGA WENDELL Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2021-08-17 | WIERENGA WENDELL Director | Conversion | +8,163 | 13,041 | ||
| 2021-08-17 | WIERENGA WENDELL Director | Conversion · Series 1d Preferred Stock | −55,078 | 0 |
Page 1 of 1 · 9 trades